CDK1 dependent phosphorylation of hTERT contributes to cancer progression.
Saved in:
| Title: | CDK1 dependent phosphorylation of hTERT contributes to cancer progression. |
|---|---|
| Authors: | Yasukawa M; Division of Cancer Stem Cell, National Cancer Center Research Institute, Tokyo, 104-0045, Japan., Ando Y; Division of Cancer Stem Cell, National Cancer Center Research Institute, Tokyo, 104-0045, Japan., Yamashita T; Department of Gastroenterology, Kanazawa University Graduate School of Medical Science, Kanazawa, 920-8641, Japan., Matsuda Y; Department of Pathology, Tokyo Metropolitan Geriatric Hospital and Institute of Gerontology, Tokyo, 173-0015, Japan.; Oncology Pathology, Department of Pathology and Host-Defense, Kagawa University, Kagawa, 761-0793, Japan., Shoji S; Laboratory for Protein Functional and Structural Biology, RIKEN Center for Biosystems Dynamics Research, Yokohama, 230-0045, Japan., Morioka MS; Preventive Medicine and Applied Genomics Unit, RIKEN Center for Integrative Medical Sciences, Yokohama, 230-0045, Japan., Kawaji H; Preventive Medicine and Applied Genomics Unit, RIKEN Center for Integrative Medical Sciences, Yokohama, 230-0045, Japan.; RIKEN Preventive Medicine and Diagnosis Innovation Program, Wako, 351-0198, Japan., Shiozawa K; Division of Rare Cancer Research, National Cancer Center Research Institute, Tokyo, 104-0045, Japan., Machitani M; Division of Cancer Stem Cell, National Cancer Center Research Institute, Tokyo, 104-0045, Japan., Abe T; Animal Resource Development Unit, RIKEN Center for Life Science Technologies, Kobe, 650-0047, Japan.; Genetic Engineering Team, RIKEN Center for Life Science Technologies, Kobe, 650-0047, Japan., Yamada S; Department of Antibody Drug Development, Tohoku University Graduate School of Medicine, Sendai, 980-8575, Japan., Kaneko MK; Department of Antibody Drug Development, Tohoku University Graduate School of Medicine, Sendai, 980-8575, Japan., Kato Y; Department of Antibody Drug Development, Tohoku University Graduate School of Medicine, Sendai, 980-8575, Japan.; New Industry Creation Hatchery Center, Tohoku University, Sendai, 980-8579, Japan., Furuta Y; Animal Resource Development Unit, RIKEN Center for Life Science Technologies, Kobe, 650-0047, Japan.; Genetic Engineering Team, RIKEN Center for Life Science Technologies, Kobe, 650-0047, Japan., Kondo T; Division of Rare Cancer Research, National Cancer Center Research Institute, Tokyo, 104-0045, Japan., Shirouzu M; Laboratory for Protein Functional and Structural Biology, RIKEN Center for Biosystems Dynamics Research, Yokohama, 230-0045, Japan., Hayashizaki Y; RIKEN Preventive Medicine and Diagnosis Innovation Program, Wako, 351-0198, Japan., Kaneko S; Department of Gastroenterology, Kanazawa University Graduate School of Medical Science, Kanazawa, 920-8641, Japan., Masutomi K; Division of Cancer Stem Cell, National Cancer Center Research Institute, Tokyo, 104-0045, Japan. kmasutom@ncc.go.jp. |
| Source: | Nature communications [Nat Commun] 2020 Mar 25; Vol. 11 (1), pp. 1557. Date of Electronic Publication: 2020 Mar 25. |
| Publication Type: | Journal Article; Research Support, Non-U.S. Gov't |
| Journal Info: | Publisher: Nature Pub. Group Country of Publication: England NLM ID: 101528555 Publication Model: Electronic Cited Medium: Internet ISSN: 2041-1723 (Electronic) Linking ISSN: 20411723 NLM ISO Abbreviation: Nat Commun Subsets: MEDLINE |
| Database: | MEDLINE Ultimate |
|
Full text is not displayed to guests.
Login for full access.
|
|
| ISSN: | 2041-1723 |
|---|---|
| DOI: | 10.1038/s41467-020-15289-7 |
